Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends
Saracco, G.; Rizzetto, M.
Recenti Progressi in Medicina 90(11): 595-600
1999
ISSN/ISBN: 0034-1193 PMID: 10608149 Document Number: 509571
Document emailed within 1 workday
Related Documents
Rodrigo Sáez, L.; Vivas Alegre, S.; Palacio Galán, M.A.; Pérez Alvarez, R.; Rodríguez García, M. 1997: Associated autoimmune hepatitis and chronic hepatitis C virus infection: diagnostic and therapeutic criteria Gastroenterologia y Hepatologia 20(1): 43-44Galský, J.; Husa, P.; Hejda, V.; Kümpel, P.; Nĕmecek, V.; Plísek, S.; Sperl, J.; Urbánek, P.; Volfová, M. 2012: Standard diagnostic and therapeutic approaches to chronic hepatitis C virus infection Klinicka Mikrobiologie a Infekcni Lekarstvi 18(3): 75-89
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Richardet, J.P.; Lons, T.; Johanet, C.; Abourached, A.; Raffoux, C.; Grimbert, S.; Sibony, M.; André, C.; Trinchet, J.C.; Homberg, J.C. 1994: Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus Gastroenterologie Clinique et Biologique 18(10): 819-823
Cartwright, C.P. 1999: Synthetic viral particles promise to be valuable in the standardization of molecular diagnostic assays for hepatitis C virus Clinical Chemistry 45(12): 2057-2059
Semenov, A.V.; Arsentieva, N.A.; Lubimova, N.E.; Tulienev, S.V.; Basina, V.V.; Esaulenko, E.V.; Totolyan, A.A. 2015: The Role of Cytokines and Chemokines in Laboratory Diagnostic of Chronic Viral Hepatitis C Klinicheskaia Laboratornaia Diagnostika 60(8): 45-51
Fusillo, A. 1973: Effect of small doses of emetine in the therapy of virus diseases. New specific therapeutic method in viral hepatitis Minerva Medica 64(3): 129-132
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Madalinski, K.; Burczynska, B.; Heermann, K.H.; Uy, A.; Gerlich, W.H. 1991: Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus Clinical and Experimental Immunology 84(3): 493-500
Csatary, L.K.; Schnabel, R.; Bakács, T. 1999: Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine Anticancer Research 19(1b): 629-633
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Müller, R. 1976: Can therapeutic measures cause a hepatitis virus infection to become chronic? Münchener Medizinische Wochenschrift 118(21): 679-682
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Romeo, F.; Russo, A.; Liuzzo, P. 1980: Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases Recenti Progressi in Medicina 69(6): 644-669
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Iushchuk, N.D.; Ogienko, O.L.; Kruglov, I.V.; Znoĭko, O.O.; Braginskiĭ, D.M.; Semiletov, I.A.; Finogenova, M.P.; Alekseenkova, T.I.; Ianina, M.V.; Shibnev, V.A.; Doroshenko, N.V. 2002: Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection Terapevticheskii Arkhiv 74(4): 18-22
Guido, M.; Rugge, M.; Colombari, R.; Cecchetto, A.; Scarpa, A.; Cadrobbi, P. 1998: Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C Italian Journal of Gastroenterology and Hepatology 30(4): 414-417
Bassa, A.; Villalonga, C.; Parras, F.; Salvà, F.; Altés, J.; Salas, A. 1989: Infection caused by the human immunodeficiency virus, hepatitis B virus and delta virus in homosexual males Medicina Clinica 93(13): 490-492
Barinskiĭ, I.F.; Nesterchuk, S.L. 1995: Killed specific viral vaccines for therapeutic use in chronic viral infections Voprosy Virusologii 40(1): 5-8